2027 Communication Download Pharmaceutical Companies 
Pharmaceutical Technology
APRIL 24, 2023
As a result, some pharmaceutical companies are turning to third parties. GlobalData forecasts Biologics to significantly overtake sales of small molecules by $120 billion by 2027. As more companies rely on CROs and CDMOs, the criteria for selecting the right partner has also changed.
Pharmaceutical Technology
FEBRUARY 6, 2023
A Pliant spokesperson said, “This successful transaction, along with existing cash, cash equivalents, loan agreement and short-term investments, provides for operations to be funded to mid-2027, a year past the expected IPF Phase 2b clinical trial readout.” The company said a Phase IIb trial initiation should be expected in mid-2023.
Expert insights. Personalized for you.
52 
Let's personalize your content